SYRS - Syros Pharmaceuticals Inc. (SYRS) CEO Nancy Simonian on Q4 2020 Results - Earnings Call Transcript
Syros Pharmaceuticals, Inc. (SYRS) Q4 2020 Earnings Conference Call March 4, 2021 8:30 AM ET Company Participants Naomi Aoki - Vice President, Corporate Communications and Investor Relations Nancy Simonian - Our Chief Executive Officer David Roth - Chief Medical Officer Joe Ferra - Chief Financial Officer Conference Call Participants Phil Nadeau - Cowen Ted Tenthoff - Piper Sandler Jason Butler - JMP Securities Mark Breidenbach - Oppenheimer Zegbeh Jallah - ROTH Capital Matthew Cross - Alliance Global Presentation Operator Good morning and welcome to Syros Pharmaceuticals Fourth Quarter and Full Year 2020 Financial Results Conference Call. At this time, all participants are in a listen-only mode. This call is being webcast live on Investors & Media section of Syros' website at www.syros.com. Please be advised that today's call is being recorded. Following the formal remarks, we will open the call up for your questions. At this time, I'd like to
For further details see:
Syros Pharmaceuticals, Inc. (SYRS) CEO Nancy Simonian on Q4 2020 Results - Earnings Call Transcript